MedTrace Logo

Efficacy of Parecoxib on Patients With CRPS

NCT01523379 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2012-04-25

No results posted yet for this study

Summary

The complex regional pain syndrom is a weighty disease that often results in a lifelong disability. Mostly this disease appears unilateral after comparatively mundane fractures or operations. In early stages CRPS shows inflammatory processes. These inflammatory components can be seen as edema and vasodilatation. These inflammatory processes lead us to the hypothesis that selective COX-2-inhibitors might help patients with CRPS.

Conditions

  • Causalgia

Interventions

DRUG

Parecoxib

90mg Parecoxib i.v. two times a day, two days in a row

DRUG

Placebo

NaCl i.v. two times a day, two days in an row

Sponsors & Collaborators

  • Ruhr University of Bochum

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01523379 on ClinicalTrials.gov